Cargando…

Prognostic Value of C4d Immunolabelling in Adult Patients With IgA Vasculitis

Background and Objectives: Glomerular C4d deposits are associated the severity and outcomes of IgA nephropathy. Whether this holds true in immunoglobulin A vasculitis (IgAV) is not known. The main objective of the study was to analyze the prognostic value of glomerular C4d immunolabelling on kidney...

Descripción completa

Detalles Bibliográficos
Autores principales: Romero, Anais, Drieux, Fanny, François, Arnaud, Dervaux, Alexandra, Xu, Xiao Li, Titeca-Beauport, Dimitri, Bertrand, Dominique, Guerrot, Dominique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666566/
https://www.ncbi.nlm.nih.gov/pubmed/34912816
http://dx.doi.org/10.3389/fmed.2021.735775
_version_ 1784614235253243904
author Romero, Anais
Drieux, Fanny
François, Arnaud
Dervaux, Alexandra
Xu, Xiao Li
Titeca-Beauport, Dimitri
Bertrand, Dominique
Guerrot, Dominique
author_facet Romero, Anais
Drieux, Fanny
François, Arnaud
Dervaux, Alexandra
Xu, Xiao Li
Titeca-Beauport, Dimitri
Bertrand, Dominique
Guerrot, Dominique
author_sort Romero, Anais
collection PubMed
description Background and Objectives: Glomerular C4d deposits are associated the severity and outcomes of IgA nephropathy. Whether this holds true in immunoglobulin A vasculitis (IgAV) is not known. The main objective of the study was to analyze the prognostic value of glomerular C4d immunolabelling on kidney impairment in adults with IgAV. Design, Setting, Participants, Measurements: This retrospective cohort study included 120 adults with IgAV and a kidney biopsy performed between 1995 and 2018 in two French university hospital centers. All paraffin-embedded biopsies were reassessed according to Oxford classification. Immunofluorescence for C4d was performed in all cases. For analysis, patients were grouped according to positivity for C4d in the glomerular area. The main outcome was a composite endpoint of 50% increase in 24 h-proteinuria, or eGFR decrease by 50%, or kidney replacement therapy. Results: The median follow-up was 28.3 months. Twenty-three patients met the composite endpoint, 12 for kidney replacement therapy, 6 for an eGFR decrease >50% and 5 for a >50% increase in proteinuria. At time of biopsy, the median proteinuria was 1.9 g/24 h and the median eGFR 73.5 mL/min/1.73 m(2). Among the 102 patients evaluable for C4d, 24 were positive on >30% glomeruli, mainly with a parieto-mesangial pattern. In this group, the initial proteinuria was more frequently nephrotic than in the C4d– group (60% vs. 33%, P = 0.039). Mesangial hypercellularity was more frequent in the C4d+ group (42% vs. 13%; P = 0.006) whereas macroscopic hematuria was more frequent in the C4d– group (18% vs. 0%; P = 0.03). After a median follow-up of 28 months, kidney survival did not differ according to C4d status. Conclusion: In a population of adult IgAV patients, glomerular positivity for C4d was associated with the severity of the kidney disease at presentation, but not with subsequent renal function deterioration.
format Online
Article
Text
id pubmed-8666566
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-86665662021-12-14 Prognostic Value of C4d Immunolabelling in Adult Patients With IgA Vasculitis Romero, Anais Drieux, Fanny François, Arnaud Dervaux, Alexandra Xu, Xiao Li Titeca-Beauport, Dimitri Bertrand, Dominique Guerrot, Dominique Front Med (Lausanne) Medicine Background and Objectives: Glomerular C4d deposits are associated the severity and outcomes of IgA nephropathy. Whether this holds true in immunoglobulin A vasculitis (IgAV) is not known. The main objective of the study was to analyze the prognostic value of glomerular C4d immunolabelling on kidney impairment in adults with IgAV. Design, Setting, Participants, Measurements: This retrospective cohort study included 120 adults with IgAV and a kidney biopsy performed between 1995 and 2018 in two French university hospital centers. All paraffin-embedded biopsies were reassessed according to Oxford classification. Immunofluorescence for C4d was performed in all cases. For analysis, patients were grouped according to positivity for C4d in the glomerular area. The main outcome was a composite endpoint of 50% increase in 24 h-proteinuria, or eGFR decrease by 50%, or kidney replacement therapy. Results: The median follow-up was 28.3 months. Twenty-three patients met the composite endpoint, 12 for kidney replacement therapy, 6 for an eGFR decrease >50% and 5 for a >50% increase in proteinuria. At time of biopsy, the median proteinuria was 1.9 g/24 h and the median eGFR 73.5 mL/min/1.73 m(2). Among the 102 patients evaluable for C4d, 24 were positive on >30% glomeruli, mainly with a parieto-mesangial pattern. In this group, the initial proteinuria was more frequently nephrotic than in the C4d– group (60% vs. 33%, P = 0.039). Mesangial hypercellularity was more frequent in the C4d+ group (42% vs. 13%; P = 0.006) whereas macroscopic hematuria was more frequent in the C4d– group (18% vs. 0%; P = 0.03). After a median follow-up of 28 months, kidney survival did not differ according to C4d status. Conclusion: In a population of adult IgAV patients, glomerular positivity for C4d was associated with the severity of the kidney disease at presentation, but not with subsequent renal function deterioration. Frontiers Media S.A. 2021-11-29 /pmc/articles/PMC8666566/ /pubmed/34912816 http://dx.doi.org/10.3389/fmed.2021.735775 Text en Copyright © 2021 Romero, Drieux, François, Dervaux, Xu, Titeca-Beauport, Bertrand and Guerrot. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Romero, Anais
Drieux, Fanny
François, Arnaud
Dervaux, Alexandra
Xu, Xiao Li
Titeca-Beauport, Dimitri
Bertrand, Dominique
Guerrot, Dominique
Prognostic Value of C4d Immunolabelling in Adult Patients With IgA Vasculitis
title Prognostic Value of C4d Immunolabelling in Adult Patients With IgA Vasculitis
title_full Prognostic Value of C4d Immunolabelling in Adult Patients With IgA Vasculitis
title_fullStr Prognostic Value of C4d Immunolabelling in Adult Patients With IgA Vasculitis
title_full_unstemmed Prognostic Value of C4d Immunolabelling in Adult Patients With IgA Vasculitis
title_short Prognostic Value of C4d Immunolabelling in Adult Patients With IgA Vasculitis
title_sort prognostic value of c4d immunolabelling in adult patients with iga vasculitis
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666566/
https://www.ncbi.nlm.nih.gov/pubmed/34912816
http://dx.doi.org/10.3389/fmed.2021.735775
work_keys_str_mv AT romeroanais prognosticvalueofc4dimmunolabellinginadultpatientswithigavasculitis
AT drieuxfanny prognosticvalueofc4dimmunolabellinginadultpatientswithigavasculitis
AT francoisarnaud prognosticvalueofc4dimmunolabellinginadultpatientswithigavasculitis
AT dervauxalexandra prognosticvalueofc4dimmunolabellinginadultpatientswithigavasculitis
AT xuxiaoli prognosticvalueofc4dimmunolabellinginadultpatientswithigavasculitis
AT titecabeauportdimitri prognosticvalueofc4dimmunolabellinginadultpatientswithigavasculitis
AT bertranddominique prognosticvalueofc4dimmunolabellinginadultpatientswithigavasculitis
AT guerrotdominique prognosticvalueofc4dimmunolabellinginadultpatientswithigavasculitis